James Loerop Aclaris Therapeutics, Inc. (ACRS) insider trading activity

ACRS Quotes by TradingView

James Loerop is Chief Business Officer of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 34,017 shares of ACRS, which is worth approximately $40,140. The most recent transaction as insider was on Feb 01, 2024, when has been sold 6,421 shares (Common Stock) at a price of $1.2 per share, resulting in proceeds of $7,705. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34K
0% 3M change
56.85% 12M change
Total Value Held $40,140

James Loerop Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
SELL
Payment of exercise price or tax liability
$7,705 $1.2 p/Share
6,421 Reduced 15.88%
34,017 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
-
18,750 Added 33.88%
36,585 Common Stock
Aug 28 2023
BUY
Open market or private purchase
$99,994 $6.8 p/Share
14,705 Added 40.41%
21,688 Common Stock
Feb 08 2023
SELL
Open market or private sale
$59,268 $13.89 p/Share
4,267 Reduced 37.93%
6,983 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
-
11,250 Added 50.0%
11,250 Common Stock

Also insider at

ANIK
Anika Therapeutics, Inc. Healthcare
EVP Business Development
JL

James Loerop

Chief Business Officer
Wayne, PA

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACRS